Application 071082
- Type
- ANDA
- Sponsor
- QUAD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | HALOPERIDOL | HALOPERIDOL LACTATE | Injectable; Injection | EQ 5MG BASE/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Haloperidol | HALOPERIDOL LACTATE | Hikma Pharmaceuticals USA Inc. | ec7a3560-71c3-43f5-bc6c-d51eadfd2aa1 | 2022-07-18 | Boxed warning, Warnings, Adverse reactions | Haloperidol HALOPERIDOL LACTATE |
| Haloperidol | HALOPERIDOL | Amici Pharmaceuticals, LLC | 9a9e20dd-646a-4fe9-a345-1b5bda8e7775 | 2022-05-02 | Boxed warning, Warnings, Adverse reactions | Haloperidol |
| HALOPERIDOL | HALOPERIDOL LACTATE | HF Acquisition Co LLC, DBA HealthFirst | beb6d1cf-98db-d0a5-e053-2995a90ace90 | 2021-03-29 | Boxed warning, Warnings, Adverse reactions | HALOPERIDOL HALOPERIDOL LACTATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.